B-Cell Malignancies (Non-Hodgkin’s Lymphoma and Chronic Lymphocytic Leukemia)

Seven ClinicalThought commentaries and an educational module provide expert discussion of strategies for managing non-Hodgkin&rsquo s lymphoma and chronic lymphocytic leukemia. Key factors affecting the management approach will be addressed including patient-specific factors and recent clinical trial data of current and emerging therapeutics.

Share

Program Content

Activities

Immune Modulation in Follicular Lymphoma
Is Immune Modulation the Future of Therapy in Follicular Lymphoma?
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: February 11, 2015

Expires: February 10, 2016

Risk-Adapted Therapy for DLBCL
Beyond R-CHOP-21: Risk-Adapted Therapy for DLBCL
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: March 10, 2015

Expires: March 08, 2016

Management of del(17p) CLL
Ibrutinib and the Management of Patients With del(17p) CLL
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: March 23, 2015

Expires: March 21, 2016

Kinase Inhibitors in Relapsed CLL
Utility of Kinase Inhibitors in the Management of Relapsed CLL
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: April 27, 2015

Expires: April 25, 2016

Targeted Therapy for iNHL
Targeted Therapy for Indolent Lymphomas: Where We Are and Where We Are Heading
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: May 26, 2015

Expires: May 24, 2016

Anti-CD20 Antibodies in CLL
Anti-CD20 Antibodies in CLL: What to Do in Regular Practice
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: July 09, 2015

Expires: July 07, 2016

Localized Follicular Lymphoma
Management of Patients With Localized Follicular Lymphoma
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: July 29, 2015

Expires: July 27, 2016

Faculty

cover img faculity

Farrukh Awan, MD, MS

Associate Professor of Internal Medicine
Division of Hematology
The Ohio State University Comprehensive Cancer Center
Arthur G. James Cancer Hospital and Richard J. Solove Research Institute
Columbus, Ohio

cover img faculity

John M. Burke, MD

Associate Chair
US Oncology Hematology Research Program
Rocky Mountain Cancer Centers
Aurora, Colorado

cover img faculity

Steven M. Horwitz, MD

Assistant Attending Physician, Lymphoma Service
Department of Medicine
Memorial Sloan-Kettering Cancer Center
New York, New York

cover img faculity

Andrew D. Zelenetz, MD, PhD

Associate Professor, Department of Medicine
Cornell University Medical College
Chief, Lymphoma Service
Memorial Sloan-Kettering Cancer Center
New York, New York

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Gilead